Lexicon Pharmaceuticals | Nettoeinkommen

Aktienkurs
1.31
Täglich Wechseln
0 0%
Monatlich
5.65%
Jährlich
66.90%
Q1 Prognose
2.01




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Coherus Biosciences USD -56.57M 5.87M 2025-03
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Illumina USD 334M 184M 2025-12
Insmed USD -370.02M 48.34M 2025-09
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
J&J USD 5.12B 36M 2025-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
MacroGenics USD 16.82M 53.07M 2025-09
MannKind USD 668K 12.49M 2025-06
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Novartis USD 3.93B 96M 2025-09
PTC Therapeutics USD 15.9M 80.75M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 338.7M 29.2M 2025-09
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12


Lexicon Pharmaceuticals Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.